About Nascent Biotech Inc Nascent Biotech, Inc. (
Post# of 21197
(Total Views: 99)
Posted On: 05/04/2022 7:20:08 AM
About Nascent Biotech Inc
Nascent Biotech, Inc. (OTCQB: $NBIO) is a clinical-stage biotech company pioneering the development of monoclonal antibodies to be used in the treatment of various cancers helping millions of people worldwide. Its products are not yet commercially available. The Company's lead candidate, Pritumumab (PTB), is a monoclonal Antibody (Mab) that is being studied in Phase I clinical trials for the treatment of Brain Cancer.
For further information please visit our website www.nascentbiotech.com.
Nascent Biotech, Inc. (OTCQB: $NBIO) is a clinical-stage biotech company pioneering the development of monoclonal antibodies to be used in the treatment of various cancers helping millions of people worldwide. Its products are not yet commercially available. The Company's lead candidate, Pritumumab (PTB), is a monoclonal Antibody (Mab) that is being studied in Phase I clinical trials for the treatment of Brain Cancer.
For further information please visit our website www.nascentbiotech.com.
(0)
(0)Scroll down for more posts ▼